News

The exhibit features 20 preserved human bodies and more than 200 anatomical parts. One display focuses on the heart and is ...
BOSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next ...
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...
BOSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next-generation ...